This ebulletin contains informationonregulating biocides in Great Britain

Having trouble viewing this email?View the content as a web page.

Health and Safety Executive logo

HSE ebulletin

Upcoming GB active substance open invitation deadline

Submit a notification by the deadline to keep active substances in the GB Review Programme

HSE has published an open invitation (.pdf) to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the GB Review Programme for the following active substance/product type combination.

Anyone wishing to support the active substance/product type combination listed below in GB will need to submit a notification to HSE by the following deadline:

  • Peanut butter (CAS n/a EC n/a) in product type 19
    14 March 2024

If a notification to take over the role of participant is not received, this active substance/product type combination will be subject to a GB non-approval decision. Biocidal products and treated articles containing active substances with GB non-approval decisions for the relevant product types will have to be removed from the GB market.

HSE will provide separate updates on these where relevant.

If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of the active substance/product type combination listed above, please contact us.


Upcoming GB active substance expiry dates

Biocidal products must be phased off the GB market

The active substance/product type combinations listed below are due to expire under the GB BPR on the following dates:

  • (RS)-4-hydroxy-3-(3-oxo-1-phenylbutyl)coumarin (Warfarin) (CAS 81-81-2 EC 201-377-6) in product type 14
    30 June 2024

  • Polyhexamethylene biguanide hydrochloride with a mean number-average molecular weight (Mn) of 1600 and a mean polydispersity (PDI) of 1.8 (PHMB (1600;1.8)) (CAS 27083-27-8 / 32289-58-0 EC n/a) in product types 02, 03 and 11
    30 June 2024

  • Chlorophacinone (CAS 3691-35-8 EC 223-003-0) in product type 14
    30 June 2024

  • 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile (Chlorfenapyr) (CAS 122453-73-0 EC 602-782-4) in product type 08
    30 April 2025

  • 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) (CAS 60207-90-1 EC 262-104-4) in product type 09
    31 May 2025

Once the approvals expire, the active substances can no longer be used in biocidal products or treated articles of the relevant product types in GB.

If you hold an affected GB BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision.

If you are aware of any disproportionate negative impacts that are likely to arise from the expiry of any of the active substance/product type combinations listed above, please contact us.

Get latest news and updates from HSE across a range of industries and topics bysubscribing to our ebulletins

GovUK footer logo

Health and Safety Executive - 5N1 Redgrave Court, Merton Road, Bootle, Merseyside L20 7HS